Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study
Crossref DOI link: https://doi.org/10.1007/s00280-014-2668-5
Published Online: 2015-01-03
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Merchan, Jaime R.
Qin, Rui
Pitot, Henry
Picus, Joel
Liu, Glenn
Fitch, Tom
Maples, William J.
Flynn, Patrick J.
Fruth, Briant F.
Erlichman, Charles
Text and Data Mining valid from 2015-01-03